Levels of alkaline phosphatase (ALP), albumin (ALB) and D dimer (DD) in bronchoalveolar lavage (BAL) in patients with Interstitial lung disease (ILD)

M. Maruzzi, M. Pecis, A. Lattuada, P. Luraschi, D. Legnani (Milan, Italy)

Source: Annual Congress 2002 - Interstitial lung disease: clinical pathobiology and BAL
Session: Interstitial lung disease: clinical pathobiology and BAL
Session type: Thematic Poster Session
Number: 2955
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Maruzzi, M. Pecis, A. Lattuada, P. Luraschi, D. Legnani (Milan, Italy). Levels of alkaline phosphatase (ALP), albumin (ALB) and D dimer (DD) in bronchoalveolar lavage (BAL) in patients with Interstitial lung disease (ILD). Eur Respir J 2002; 20: Suppl. 38, 2955

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), C-reaktive protein (CRP), albumin (ALB) and alkaline phosphatase (ALP) in bronchoalveolar lavage fluid (BALF) of patients with interstitial lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006

Trace elements (TE) in broncho-alveolar lavage fluid (BALF) and corresponding serum (SE) of patients with inflammatory and neoplastic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 465s
Year: 2002

Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Bronchoalveolar lavage fluid (BALF) phospholipids (PL) and tumor necrosis factor-α (TNF-α) produced by alveolar macrophages (AM) can be used for predicting the course of sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 468s
Year: 2002

Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003

Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

IL-8, VEGF and TGFβ levels in serum (S) and bronchoalveolar lavage (BAL) of rabbits submitted to intrapleural injection of two different types of talc
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008


Chitotriosidase as a possible marker of sarcoidosis activity
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Elevated apoptosis rate of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonitis (NSIP) – strong positive correlation with bronchoalvoelar lavage (BAL) neutrophil count.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020

Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF)
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Comparison between exhaled and bronchoalveolar lavage (BAL) levels of hydrogen peroxide (H2O2) in patients with diffuse interstitial lung diseases (DILD)
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis-usual interstitial pneumonia (IPF-UIP) using SELDI-mass spectrometry
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007


Prognostic value of cytokeratin 19 in bronchoalveolar lavage (BAL) in patients with acute lung injury (ALI)
Source: Eur Respir J 2002; 20: Suppl. 38, 599s
Year: 2002

Flow cytometry (FC) in examination of broncholaveolar lavage (BAL) in interstitial lung diseases (ILD). Presentation of 14 years‘ experience
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Diagnostic value of induced sputum (IS) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003

Comparative evaluation of alkaline phosphatase (ALP) & adenosine deaminase (ADA) in pleural fluid and serum of patients with pleural effusions
Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases
Year: 2011


The diagnostic value of bronchoalvolar lavage (BAL) in the diagnosis of peripheral lung cancer (PLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

The Gender-Age-Physiology (GAP) Index enhanced with KL-6 serum level for predicting disease progression in interstitial lung diseases (ILD).
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020